LLY

884.96

-0.04%↓

NVO

141.87

+0.6%↑

UNH

482.42

-0.43%↓

JNJ

148.65

+0.6%↑

MRK

130.24

+0.4%↑

LLY

884.96

-0.04%↓

NVO

141.87

+0.6%↑

UNH

482.42

-0.43%↓

JNJ

148.65

+0.6%↑

MRK

130.24

+0.4%↑

LLY

884.96

-0.04%↓

NVO

141.87

+0.6%↑

UNH

482.42

-0.43%↓

JNJ

148.65

+0.6%↑

MRK

130.24

+0.4%↑

LLY

884.96

-0.04%↓

NVO

141.87

+0.6%↑

UNH

482.42

-0.43%↓

JNJ

148.65

+0.6%↑

MRK

130.24

+0.4%↑

LLY

884.96

-0.04%↓

NVO

141.87

+0.6%↑

UNH

482.42

-0.43%↓

JNJ

148.65

+0.6%↑

MRK

130.24

+0.4%↑

Search

Becton Dickinson and Co

Closed

Sector Healthcare

238.09 -0.07

Overview

Share price change

24h

Current

Min

237.16

Max

238.54

Key metrics

By Trading Economics

Income

255M

537M

Sales

344M

5.1B

P/E

Sector Avg

47.614

23.904

EPS

3.17

Dividend yield

1.379

Profit margin

10.634

Employees

73,000

EBITDA

215M

1.3B

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+18.34 upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

1.38%

7.76%

Next Earnings

1 sie 2024

Next Dividend date

28 cze 2024

Next Ex Dividend date

5 wrz 2024

Market Stats

By TradingEconomics

Market Cap

-2B

67B

Previous open

238.16

Previous close

238.09

News Sentiment

By Acuity

28%

72%

50 / 369 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Bullish Evidence

Becton Dickinson and Co Chart

Related News

3 cze 2024, 11:18 UTC

Acquisitions, Mergers, Takeovers

Becton Dickinson to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion in Cash

2 maj 2024, 11:07 UTC

Earnings

Becton Dickinson Shakes Up 2024 Outlook After Growing 2Q Sales, Earnings

1 lut 2024, 12:04 UTC

Earnings

Becton Dickinson Lifts 2024 Outlook After Sales Rise in 1Q

4 cze 2024, 17:26 UTC

Acquisitions, Mergers, Takeovers

Edwards Lifesciences Deal A Clear Win For Becton Dickinson, Analysts Say -- Analysis

3 cze 2024, 15:30 UTC

Hot Stocks

Stocks to Watch Monday: GameStop, AMC, Paramount, Nvidia -- WSJ

3 cze 2024, 13:26 UTC

Acquisitions, Mergers, Takeovers

Edwards Lifesciences Stock Nears Breakout On A Surprise $4.2 Billion Deal -- IBD

3 cze 2024, 12:25 UTC

Top News
Acquisitions, Mergers, Takeovers

Becton Dickinson to Acquire Edwards Lifesciences' Unit for $4.2 Billion in Cash -- Update

3 cze 2024, 11:03 UTC

Top News
Acquisitions, Mergers, Takeovers

Becton Dickinson to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2B in Cash

3 cze 2024, 10:40 UTC

Acquisitions, Mergers, Takeovers

Edwards Lifesciences To Sell Its Critical Care Product Group For $4.2 Billion To Becton Dickinson -- MarketWatch

3 cze 2024, 10:32 UTC

Acquisitions, Mergers, Takeovers

Becton Dickinson: Acquired Business Has About 4,500 Employees >BDX EW

3 cze 2024, 10:31 UTC

Acquisitions, Mergers, Takeovers

Becton Dickinson: Acquired Business Generated More Than $900 Million Revenue in 2023 >BDX

3 cze 2024, 10:31 UTC

Acquisitions, Mergers, Takeovers

Becton Dickinson: Deal Expands Portfolio of Smart Connected Care Solutions >BDX EW

3 cze 2024, 10:30 UTC

Acquisitions, Mergers, Takeovers

Becton Dickinson to Buy Edwards Lifesciences Critical Care Product Group for $4.2 Billion >BDX EW

3 cze 2024, 10:30 UTC

Acquisitions, Mergers, Takeovers

BD To Acquire Edwards Lifesciences' Critical Care Product Group For $4.2 Billion To Expand Smart Connected Care Solutions And Become An Advanced Monitoring Technology Leader >BDX EW

2 maj 2024, 10:35 UTC

Earnings

Becton Dickinson Had Seen FY24 Adjusted EPS $12.82-$13.06 >BDX

2 maj 2024, 10:34 UTC

Earnings

Becton Dickinson Raises FY24 View To Adj EPS $12.95-Adj EPS $13.15 >BDX

2 maj 2024, 10:34 UTC

Earnings

Becton Dickinson Still Sees FY24 Organic Revenue Growth of 5.5%-6.25% >BDX

2 maj 2024, 10:33 UTC

Earnings

Becton Dickinson Had Seen FY24 Revenue $20.2B-$20.4B >BDX

2 maj 2024, 10:33 UTC

Earnings

Becton Dickinson Cuts FY24 View To Rev $20.1B-$20.3B >BDX

2 maj 2024, 10:30 UTC

Earnings

Becton Dickinson 2Q Net $537M >BDX

2 maj 2024, 10:30 UTC

Earnings

Becton Dickinson 2Q Adj EPS $3.17 >BDX

2 maj 2024, 10:30 UTC

Earnings

Becton Dickinson 2Q EPS $1.85 >BDX

2 maj 2024, 10:30 UTC

Earnings

Becton Dickinson 2Q Rev $5B >BDX

27 mar 2024, 21:59 UTC

Acquisitions, Mergers, Takeovers

3M's Healthcare Spinoff Stock Fell. This Is What It's Worth. -- Barrons.com

27 mar 2024, 09:15 UTC

Acquisitions, Mergers, Takeovers

3M's Healthcare Spinoff Stock Is Trading. This Is What It's Worth. -- Barrons.com

1 lut 2024, 11:34 UTC

Earnings

Becton Dickinson Sees FY24 Currency-Neutral Rev Growth 4.75%-5.5% >BDX

1 lut 2024, 11:33 UTC

Earnings

Becton Dickinson Sees FY24 Organic Rev Growth 5.5%-6.25% >BDX

1 lut 2024, 11:30 UTC

Earnings

Becton Dickinson 1Q Net $281M >BDX

1 lut 2024, 11:30 UTC

Earnings

Becton Dickinson Sees FY Adj EPS $12.82-Adj EPS $13.06 >BDX

1 lut 2024, 11:30 UTC

Earnings

Becton Dickinson 1Q EPS 96c >BDX

Peer Comparison

Price change

Becton Dickinson and Co Forecast

Price Target

By TipRanks

18.34% upside

12 Months Forecast

Average 282 USD  18.34%

High 312 USD

Low 260 USD

Based on 10 Wall Street analysts offering 12 month price targets forBecton Dickinson and Co - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

10 ratings

8

Buy

2

Hold

0

Sell

Technical Score

By Trading Central

233.15 / 239.51Support & Resistance

Short Term

Bullish Evidence

Intermediate Term

Bullish Evidence

Long Term

No Evidence

Sentiment

By Acuity

50 / 369 Ranking in Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Becton Dickinson and Co

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through segments such as BD Medical, BD Life Sciences and BD Interventional. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. BD Medical consists of various business units, including medication delivery solutions, medication management solutions, diabetes care and pharmaceutical systems. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. The BD Interventional segment provides vascular, urology, oncology and surgical specialty products.